Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline
Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline, Zelfmoordlijn 1813, to Promote Continuity of Care
University Ghent
98 participants
Jan 5, 2026
INTERVENTIONAL
Conditions
Summary
This pilot study aims to assess the acceptance, feasibility, and added value of follow-up calls at the suicide helpline, Zelfmoordlijn 1813, in Flanders (Belgium). It serves as a crucial preparatory step in the development and implementation process of the callback methodology at Zelfmoordlijn 1813.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Callers of Zelfmoordlijn 1813 are called back after their initial conversation, in which they themselves contacted the Zelfmoordlijn 1813. The callbacks focus on crisis management at the Zelfmoordlijn 1813 and are not intended as a form of formal support. During the callback calls, the specific needs of the caller are addressed, tailored to the callback profile assigned by a call responder based on the initial call. There are three different callback profiles for callers: (1) those for whom the crisis call immediately focuses on creating safety, with the callback calls further reinforcing this safety, (2) those for whom the focus is on crisis management, with follow-up aimed at developing and implementing a Safety Plan, and (3) those who experience barriers to discussing their suicidal thoughts, with the callback conversations being used to facilitate the step towards professional help or to make suicide discussable within their own network or existing support services.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07343258